XT
CLBT icon

XTX Topco’s Cellebrite CLBT Stock Holding History

XTX Topco’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-158,467
Closed -$2.18M – 4202
2026
Q1 		$2.18M Buy
+158,467
New +$2.39M 0.04% 765
2025
Q2 		– Sell
-35,095
Closed -$682K – 2451
2025
Q1 		$682K Buy
35,095
+9,518
+37% +$200K 0.03% 800
2024
Q4 		$563K Sell
25,577
-30,783
-55% -$592K 0.05% 670
2024
Q3 		$949K Buy
56,360
+22,416
+66% +$333K 0.07% 446
2024
Q2 		$406K Sell
33,944
-22,923
-40% -$256K 0.03% 770
2024
Q1 		$630K Sell
56,867
-1,062
-2% -$10.8K 0.08% 352
2023
Q4 		$502K Buy
+57,929
New +$450K 0.11% 258

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

XTX Topco's CLBT Position: Q2 2026 in Review

XTX Topco sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 158,467 shares — an estimated $2.18M sold.

XTX Topco first reported a position in CLBT in Q4 2023 and held it in 7 quarters. The position peaked at $2.18M in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • XTX Topco reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 158,467 Cellebrite shares in Q2 2026, an estimated $2.18M.
  • XTX Topco first reported a position in Cellebrite in Q4 2023 and held it in 7 quarters.
  • XTX Topco's Cellebrite position peaked at $2.18M in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.